Figure 4.
Duration of Treatment and Response by Tumor Type and BRCA Mutation Status (RECIST v1.1) in the Overall Population (N = 15). aDiscontinued due to reasons other than AE or PD; bDiscontinued due to AE unrelated to treatment; cDiscontinued due to AE that was possibly treatment related. The first dot for each bar indicates timepoint when best overall response was achieved. Abbreviations: BRCA, breast cancer susceptibility gene; RECIST, Response Evaluation Criteria in Solid Tumors